Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

When Will EU Commission, Member States React To Calls For Extending Regulation Deadlines?

Executive Summary

The EU medtech sector, seeing itself heading for a crisis, is hoping the authorities will imminently extend deadlines for the Medical Device and IVD Regulations. What more do we know after last week's crucial Medical Device Coordination Group meeting?

You may also be interested in...



Medtech Makes Headway In EU HTA Debate, But More Concessions Sought

The European Parliament adopted legislation that would establish an EU-wide system for joint clinical health technology assessments including amendments supported by the device industry. But companies are looking to make the plan less prescriptive when it moves to the EU Council.

Can EU Regulations Be Changed To Allow For More Time? MedTech Europe Says 'Yes'

Huge numbers of products risk failing to comply the new EU regulations in time. Are efforts to extend deadlines legally and practically possible and will they be supported? MedTech Europe's Oliver Bisazza talks with Medtech Insight.

Critical EU Authorities Meeting Next Week Could Be Make-Or-Break For Many Medtech Companies

The EU medtech industry is trying to put the brakes on the full application of the new Medical Devices and IVD Regulation as a logjam looms. What is it doing to succeed? And why is time running out?

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel